Beijing Sun-Novo and Zhejiang Anglikang Deepen Ties with New Drug Development Partnership

Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621), a pharmaceutical company based in China, has entered into another partnership with fellow Chinese firm Zhejiang Anglikang Pharmaceutical Co., Ltd (SHE: 002940). The two companies had previously agreed to collaborate on the development of modified drugs and are now expanding their collaboration to focus on drug development strategies that align with future marketing trends. Financial specifics of the partnership were not disclosed.- Flcube.com